相关实验视频
Updated: Jul 12, 2025

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
19.7K
各种射频废除导管在废除典型心房的比较有效性
Asher Gorantla1, Mahmoud Alsaiqali1, Jonathan Francois2
1Department of Medicine, SUNY Health Sciences University, Brooklyn, NY, USA.
Cardiology and therapy
|October 20, 2023
概括
对于典型的心房动 (AFL) 的射频移除是非常成功的,不管导管类型. 接触力导管和高功率短时间设置减少了手术时间.
科学领域:
- 电力生理学 电力生理学
- 心脏病学 心脏病学
- 医疗器械 医疗器械
背景情况:
- 典型的心房动 (AFL) 射频除 (RF) 是有效的.
- 有限的比较数据存在于AFL治疗中的不同废除导管疗效.
研究的目的:
- 为了比较不同类型的AFL的废除导管的疗效.
- 评估不同导管技术对手术成功和效率的影响.
主要方法:
- 追溯分析222名为典型的AFL进行射频切除术的患者,由单个操作人员进行.
- 由双向导电阻定义的切除成功 (横向导电时间≥130毫秒或双电位≥90毫秒).
- 非灌,内部灌和外部灌 (力传感和非力传感) 导管的比较,包括高功率短期 (HPSD) 设置.
主要成果:
- 总体成功率很高 (97.3%),基于导管类型没有统计学上显著的差异.
- 外部灌,带有HPSD设置的强度感应导管显著减少了总损伤时间 (758.3秒).
- 低功耗长时间 (LPLD) 设置也减少了损伤时间 (419.0秒). 没有报告任何并发症.
结论:
- 导管类型不会影响典型的AFL射频除的成功率.
- 接触力传感技术和HPSD设置与较短的总损伤时间有关,提高了程序效率.
相关概念视频
Varicose Veins II: Diagnostic Studies and Interprofessional Care
14
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
14
Disturbances in Heart Rhythm
977
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
977
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
848
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
848
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
22
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
22
Dysrhythmias VI: Management of Dysrhythmias
17
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
17
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
751
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
751

